Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
5
×
life sciences
national blog main
boston blog main
boston top stories
clinical trials
san francisco blog main
boston
investing
new york blog main
new york top stories
san francisco top stories
startups
biotech ipos
fda
medical device
national top stories
rare diseases
renaissance capital
10x genomics
480 biomedical
abbvie
acute myeloid leukemia
allergan
alx oncology
alzheimer's disease
arsenal medical
autoimmune diseases
azacitidine
berkeley lights
beta-thalassemia
bob langer
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
chronic rhinosinusitis
covid-19
crispr
What
biotech
5
×
ipo
new
research
companies
developing
life
markets
medicines
public
raised
science
street
therapeutics
wall
way
week
welcomed
abbvie
aims
alliance
approach
arrival
based
boost
called
company
days
debut
debuts
drugs
editas
editing
epigenetic
epigenetics
exits
experimental
field
flagship’s
followed
Language
unset
5
×
Current search:
deals
×
biotech
×
unset
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M